Amyotrophic lateral sclerosis

Authors

  • June Landa Alberdi Donostia Unibertsitate Ospitalea
  • Larraitz Leunda Eizmendi Donostia Unibertsitate Ospitalea
  • Miren Ercilla Liceaga Donostia Unibertsitate Ospitalea
  • Maitane Umerez Igartua Donostia Unibertsitate Ospitalea
  • Aitziber Lizardi Mutuberria Donostia Unibertsitate Ospitalea
  • Miren Josune Garcia de Andoin Barandiaran Donostia Unibertsitate Ospitalea
  • Mikel Urretavizcaya Anton Donostia Unibertsitate Ospitalea

Keywords:

amyotrophic lateral sclerosis, neurodegenerative disease

Abstract

Amyotrophic lateral sclerosis (ALS) is an idiopathic, fatal neurodegenerative disease of the human motor system, causing muscle weakness, which can lead to paralysis. Patients can present difficulties in oral communication, swallowing, motor autonomy and breathing. However, sensitivity, sphincter control and eye muscles’ activity are preserved. It’s an incurable disease, and there is only one drug in the market that can extend longevity: riluzole. The life expectancy is short, causing death within 4-5 years in most patients.

Downloads

Published

2019-12-27

How to Cite

Landa Alberdi, J., Leunda Eizmendi, L., Ercilla Liceaga, M., Umerez Igartua, M., Lizardi Mutuberria, A., Garcia de Andoin Barandiaran, M. J., & Urretavizcaya Anton, M. (2019). Amyotrophic lateral sclerosis. Osagaiz: Osasun-Zientzien Aldizkaria, 3(2). Retrieved from https://aldizkariak.ueu.eus/index.php/osagaiz/article/view/275

Issue

Vol. 3 No. 2 (2019)

Section

Farmazialarien Txokoa